Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$34.99 – $35.51
0% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $347.1M | $331.2M | $344.9M | $36.50B | $302.1M | $38.98B | $39.10B | $39.14B |
| Cost of revenue | $219.7M | $206.3M | $211.8M | $199.8M | $182.1M | $180.0M | $26.04B | $26.52B |
| Gross profit | $127.4M | $124.9M | $133.1M | $130.5M | $120.0M | $113.4M | $13.06B | $12.62B |
| Gross margin | 36.7% | 37.7% | 38.6% | 0.4% | 39.7% | 0.3% | 33.4% | 32.2% |
| R&D | $4.0M | $7.1M | $5.6M | $6.1M | $3.6M | $2.9M | $297.0M | $0 |
| Operating income | $49.2M | $39.6M | $49.2M | $5.63B | $6.13B | $6.63B | $4.17B | $3.81B |
| EBITDA | $11.47B | $10.01B | $10.59B | $10.18B | $10.25B | $10.25B | $10.71B | $8.74B |
| Net income | $49.5M | $54.6M | $51.2M | $4.96B | $4.37B | $4.32B | $2.80B | $1.52B |
| Net margin | 14.3% | 16.5% | 14.9% | 13.6% | 1446.4% | 11.1% | 7.2% | 3.9% |
| EPS (diluted) | 1.58 | 1.79 | 1.70 | 164.03 | 153.00 | 177.95 | 115.54 | 67.98 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $38.2B | $0.89 | $0.89–$0.89 | 1 |
| 2028 | $38.9B | $0.95 | $0.95–$0.95 | 1 |
| 2029 | $41.5B | $1.07 | $1.07–$1.07 | 1 |
| 2030 | $43.1B | $1.58 | $1.58–$1.58 | 1 |
Forward consensus · source: Financial Modeling Prep
HOGY MEDICAL CO LTD
No one on the platform currently holds HGYMF.
No tracked institution reports a position in HGYMF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-09-30 | $23.7500 | 2025-11-28 |
| 2025-06-30 | $23.7500 | 2025-08-29 |
| 2025-03-31 | $20.0000 | 2025-05-30 |
| 2024-12-31 | $20.0000 | 2025-02-28 |
| 2024-09-30 | $20.0000 | 2024-11-29 |
| 2024-06-28 | $20.0000 | 2024-08-30 |
| 2024-03-28 | $20.0000 | 2024-05-31 |
| 2023-12-29 | $20.0000 | 2024-02-29 |
| 2023-09-29 | $20.0000 | 2023-11-30 |
No one on the platform has traded HGYMF yet.
| $1.1B |
| — |
| MDRXVeradigm Inc. | $5.00 | -1.96% | $849M | — |
| NNCSFNanosonics Limited | $2.55 | +0.00% | $762M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.